Form 4 for MIRA MIRA PHARMACEUTICALS, INC.
Accepted 2024-05-22 00:00:00 ET · period of report 2024-05-21 · accession 0001493152-24-021069 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-05-22 | 2024-05-21 | MIRA | Aminov Erez | CEO, Dir | P - Purchase | $0.9398 | +8,700 | 380.0K | +2% | +$8,176 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-21 | P | A | 600 | $0.87 | 380,600 | D | — | — | (F1) These securities are directly owned by Mr. Aminov. |
| 2 | Common | Common Stock | 2024-05-21 | P | A | 800 | $1.01 | 381,400 | D | — | — | (F1) These securities are directly owned by Mr. Aminov. |
| 3 | Common | Common Stock | 2024-05-21 | P | A | 2,000 | $1.00 | 375,500 | D | — | — | (F1) These securities are directly owned by Mr. Aminov. |
| 4 | Common | Common Stock | 2024-05-21 | P | A | 500 | $1.02 | 377,000 | D | — | — | (F1) These securities are directly owned by Mr. Aminov. |
| 5 | Common | Common Stock | 2024-05-21 | P | A | 1,000 | $1.03 | 376,500 | D | — | — | (F1) These securities are directly owned by Mr. Aminov. |
| 6 | Common | Common Stock | 2024-05-21 | P | A | 800 | $0.97 | 382,200 | D | — | — | (F1) These securities are directly owned by Mr. Aminov. |
| 7 | Common | Common Stock | 2024-05-21 | P | A | 2,000 | $0.84 | 379,000 | D | — | — | (F1) These securities are directly owned by Mr. Aminov. |
| 8 | Common | Common Stock | 2024-05-21 | P | A | 1,000 | $0.85 | 380,000 | D | — | — | (F1) These securities are directly owned by Mr. Aminov. |